On May 20, 2019, the Pierre Fabre Foundation honored the 6 laureates of the Occitanie 2019 call project application, including Franck Mennechet’s project: Laboratory “Adenovirus: receptors, trafficking, immunogenicity & vectorology “ Location: IGMM, CNRS Project leader: Franck Mennechet (MCU University of Montpellier) Laboratory Director: Eric J Kremer (DR1 – INSERM) Océane Paris ( PhD) at the University of Montpellier – … Continue reading Pierre Fabre Foundation : Laureate 2019
FRM LR Committee celebrated on 13 May 2019 at the Opera Comédie in Montpellier, the winners of national FRM foundation, with the presence of donors and many personalities. Of the fourteen winners, three from the IGMM: – Maelle Bellec (team M. Lagha) – Adham Safieddine (E. Bertrand team) – Eric Soler (E. Soler team)
Openings for Group Leaders in Innovative Biology Institute of Molecular Genetics, Montpellier, France The Montpellier Institute of Molecular Genetics (IGMM) – a CNRS centre for basic research – has openings for junior or established group leaders. IGMM currently hosts 18 teams working on RNA biogenesis, epigenetic regulation, chromatin biology, cell cycle, cancer, cell death, gene expression, virology and immune cell … Continue reading Open positions for junior or established group leaders in the field of innovative biology
Transcription factors (TFs) act in a combinatorial manner competing and collaborating to regulate their target genes. Several questions remain regarding the conservation of these combinations among different gene classes, regulatory regions and cell types. Here we propose a new machine learning approach able to infer these combinations of TFs. This approach demonstrates that TF combinatorics are conserved for different gene … Continue reading Machine learning to probe transcription factor combinatorics
In this work, published in Cell Reports, Lassot et al. (« Molecular Mechanisms of Apoptosis Regulation»; Solange Desagher) describe a pathway regulating α-synuclein expression with in vivo and pathological relevance. Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Although most cases of PD are sporadic, over 10% are associated with mutations in genes. SNCA, which encodes α-synuclein, … Continue reading Identification of a pathway regulating α-synuclein expression that could be used to develop new therapeutic strategies for Parkinson’s disease.
Failure to eliminate cancer cells by apoptosis is crucial in tumor development. Therefore, the key approach to achieving successful antitumor response is to harness strategies allowing the elimination of pro-survival factors to the tumor. BCL2A1 is involved in chemoresistance of melanoma and is not targeted by BH3-mimetic inhibitors. In this study Lionnard et al reveal that TRIM28 and TRIM17 are … Continue reading Two TRIM proteins control the degradation and the anti-apoptotic activity of BCL2A1 in melanoma cells.
In a work published in Genome Research, Marie-Odile Baudement and its colleagues (team « Genome organization and epigenetic control » led by Thierry Forné), have developed the HRS-seq, a new straightforward genome-wide approach whereby they isolated and sequenced genomic regions associated with nuclear bodies and other membrane-less nuclear organelles which are made insoluble through high-salt treatments (HRS – High-salt Recovered … Continue reading HRS-seq : a new genomic method reveals the importance of nuclear bodies in organizing the active chromosomal compartment